[go: up one dir, main page]

FR2785903B1 - Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique - Google Patents

Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique

Info

Publication number
FR2785903B1
FR2785903B1 FR9814398A FR9814398A FR2785903B1 FR 2785903 B1 FR2785903 B1 FR 2785903B1 FR 9814398 A FR9814398 A FR 9814398A FR 9814398 A FR9814398 A FR 9814398A FR 2785903 B1 FR2785903 B1 FR 2785903B1
Authority
FR
France
Prior art keywords
aminoethylquinoleine
derivatives
preparation
therapeutic application
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9814398A
Other languages
English (en)
Other versions
FR2785903A1 (fr
Inventor
Christophe Philippo
Patrick Mougenot
Gerard Defosse
Alain Braun
Philippe R Bovy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9814398A priority Critical patent/FR2785903B1/fr
Priority to AU11660/00A priority patent/AU1166000A/en
Priority to PCT/FR1999/002760 priority patent/WO2000029379A1/fr
Priority to US09/831,442 priority patent/US6331549B1/en
Priority to EP99972204A priority patent/EP1131293A1/fr
Priority to JP2000582366A priority patent/JP2002529533A/ja
Publication of FR2785903A1 publication Critical patent/FR2785903A1/fr
Application granted granted Critical
Publication of FR2785903B1 publication Critical patent/FR2785903B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FR9814398A 1998-11-17 1998-11-17 Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique Expired - Fee Related FR2785903B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9814398A FR2785903B1 (fr) 1998-11-17 1998-11-17 Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
AU11660/00A AU1166000A (en) 1998-11-17 1999-11-10 1-aminoethylquinoline derivatives for treating urinary incontinence
PCT/FR1999/002760 WO2000029379A1 (fr) 1998-11-17 1999-11-10 Derives de 1-aminoethylquinoleine pour le traitement de l'incontinence urinaire
US09/831,442 US6331549B1 (en) 1998-11-17 1999-11-10 1-aminoethylquinoline derivatives for treating urinary incontinence
EP99972204A EP1131293A1 (fr) 1998-11-17 1999-11-10 Derives de 1-aminoethylquinoleine pour le traitement de l'incontinence urinaire
JP2000582366A JP2002529533A (ja) 1998-11-17 1999-11-10 尿失禁治療用１−アミノエチルキノリン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814398A FR2785903B1 (fr) 1998-11-17 1998-11-17 Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2785903A1 FR2785903A1 (fr) 2000-05-19
FR2785903B1 true FR2785903B1 (fr) 2002-10-25

Family

ID=9532799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9814398A Expired - Fee Related FR2785903B1 (fr) 1998-11-17 1998-11-17 Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique

Country Status (6)

Country Link
US (1) US6331549B1 (fr)
EP (1) EP1131293A1 (fr)
JP (1) JP2002529533A (fr)
AU (1) AU1166000A (fr)
FR (1) FR2785903B1 (fr)
WO (1) WO2000029379A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801589A1 (fr) * 1999-11-25 2001-06-01 Sanofi Synthelabo Derives de 2-arylquinoleine, leur preparation et leur application en therapeutique
US6897892B2 (en) 2000-10-13 2005-05-24 Alexander L. Kormos System and method for forming images for display in a vehicle
US6789901B1 (en) 2002-01-04 2004-09-14 Raytheon Company System and method for providing images for an operator of a vehicle
US6808274B2 (en) 2002-06-04 2004-10-26 Raytheon Company Method and system for deploying a mirror assembly from a recessed position

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506157A (ja) * 1996-03-08 2000-05-23 サンテラボ （２―アミノエチル）ベンゾフラン誘導体、その製造およびその治療的使用
FR2752840A1 (fr) * 1996-08-29 1998-03-06 Synthelabo Derives de benzothiophene, leur preparation et leur application en therapeutique
FR2752839B1 (fr) * 1996-08-29 1998-10-09 Synthelabo Derives de benzofurane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AU1166000A (en) 2000-06-05
JP2002529533A (ja) 2002-09-10
FR2785903A1 (fr) 2000-05-19
WO2000029379A1 (fr) 2000-05-25
US6331549B1 (en) 2001-12-18
EP1131293A1 (fr) 2001-09-12

Similar Documents

Publication Publication Date Title
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
FR2786770B1 (fr) Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2786769B1 (fr) Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2809731B1 (fr) Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2766823B1 (fr) Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2728570B1 (fr) Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2805815B1 (fr) Derives de polyfluoroalkylimidazole, leur preparation et leur application en therapeutique
FR2792634B1 (fr) Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2754261B1 (fr) Derives de quinuclidine, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2816619B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse